Takeaways: UM171 was discovered at Université de Montréal, so this deal keeps a Canadian‑origin innovation tied to a Canadian commercial partner, aligning with domestic priorities around life‑sc...
Takeaways: Quaebec’s reimbursement of Vanflyta is a pivotal step toward pan‑Canadian access for a high‑value, biomarker‑targeted AML therapy. Market-wise, public funding acr...
